Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1387734

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1387734

Nucleic Acid Based Gene Therapy Global Market Report 2024

Published: Pre-Order
PAGES: 250 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

“Nucleic Acid Based Gene Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleic acid based gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nucleic acid based gene therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The nucleic acid based gene therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Anti-Sence and Anti-Gene; Short Inhibitory Sequences; Gene Transfer Therapy; Nucleoside Analogs; Ribozymes; Aptamers; Other Technologies
  • 2) By Application: Oncology; Muscular Dystrophy/ Muscular Disorders; Rare Diseases
  • 3) By End User: Hospitals And Clinics; Academic And Research Institutes
  • Companies Mentioned: Celsion Corporation; Wave Life Sciences; Imugene Ltd.; Caperna LLC; Phylogica Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Gene therapy aims to correct faulty genes responsible for disease development, while nucleic acid-based therapeutics are employed to address genetic disorders and conditions without a definitive cure, such as anemia, sickle cell disease, cystic fibrosis, and thalassemia.

The key technologies include anti-sense and anti-gene strategies, short inhibitory sequences, gene transfer therapy, nucleoside analogues, ribozymes, aptamers, and other innovative approaches. Nucleoside analogues, a significant class of antiviral agents, are commonly utilized to combat conditions like human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and cytomegalovirus (CMV) infections.

These therapeutic approaches find applications in various medical fields, including oncology, the management of conditions like muscular dystrophy and muscular disorders, and the treatment of rare diseases. They are implemented by end-users, including hospitals, clinics, academic institutions, and research centers, where cutting-edge research and development efforts are often carried out.

The nucleic acid-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides nucleic acid-based gene therapy market statistics, including nucleic acid-based gene therapy industry global market size, regional shares, competitors with a nucleic acid-based gene therapy market share, detailed nucleic acid-based gene therapy market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid-based gene therapy industry. This nucleic acid-based gene therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid based gene therapy market size has grown strongly in recent years. It will grow from $0.75 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth observed during the historic period in the field of gene therapy and nucleic acid-based therapeutics can be attributed to several key factors, including the increasing comprehension of human genetics, a rising demand for personalized medicine, the expansion of pipelines for gene therapy products, and growing government support for gene therapy, particularly in addressing genetic disorders and cancer therapy.

The nucleic acid based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The expected growth in the forecast period in the field of gene therapy and nucleic acid-based therapeutics can be attributed to several factors, including the broadening of therapeutic indications, increased funding for research and development, the influence of patient advocacy and growing awareness, rising investments in gene therapy research, and the expanding scope of applications for gene therapy, particularly in addressing rare diseases. Noteworthy trends anticipated during the forecast period include advancements in ex vivo gene editing, in vivo gene editing techniques, the exploration of combination therapies, the development of targeted delivery systems, the use of gene editing for rare diseases, and the adoption of non-viral vectors to enhance the effectiveness of these therapies.

The nucleic acid-based gene therapy market is expected to experience increased demand due to growing financial support from both governments and companies. Nucleic acid therapeutics, which mimic naturally occurring acids or proteins responsible for genetic expression, offer a promising approach to treating diseases such as cystic fibrosis, hemophilia, sickle cell anemia, thalassemia, and diabetes, for which traditional therapies lack a cure. These therapies target the genetic basis of diseases and hold the potential for permanent solutions. For example, the National Institute of Health (NIH) announced a $34 million annual investment over five years in August 2022 to advance HIV treatment research. Such government support and investments in gene therapies are expected to boost the nucleic acid-based gene therapy market.

The expanding healthcare expenditure is set to drive the future growth of the nucleic acid gene therapy market. Healthcare expenditure encompasses the total spending on healthcare-related goods and services within a healthcare system or economy and plays a critical role in supporting the development and accessibility of nucleic acid gene therapy. In 2022, healthcare expenditure in the United States increased by 0.8%, reaching $331 billion, up from 7.6% in 2021, as reported by the Canadian Institute for Health Information. This rise in healthcare spending contributes to the growth of the nucleic acid gene therapy market.

The stringent regulations imposed on gene therapies can lead to increased prices for these therapies, posing a hindrance to the demand for nucleic acid-based gene therapies. The complex regulatory oversight results in expensive and time-consuming approval processes, significantly raising costs. Gene therapies, unlike other FDA-regulated drugs, are subject to additional regulatory bodies, such as the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. According to estimates by the Foundation for Economic Education (FEE), the cost of developing an approved gene therapy drug is nearly $5.0 billion, which is five times higher than the average cost of FDA-approved drugs. These high costs make gene therapeutics less accessible to the general population and are likely to limit the growth of the nucleic acid-based gene therapy market.

Leading companies in the nucleic acid drugs market are actively developing innovative therapies, such as Casimersen, to drive market revenues. Casimersen, an antisense oligonucleotide (ASO), is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients with a specific mutation amenable to exon 45 skipping. Sarepta Therapeutics Inc., a US-based biotechnology company, launched Casimersen (Amondys 45) in February 2021, following FDA approval. This innovation is based on a significant increase in dystrophin production observed in patients treated with AMONDYS 45, with the potential for clinical benefits in those with exon 45 amenable mutations.

Companies operating in the nucleic acid-based gene therapy market are strategically pursuing partnerships and collaborations to enhance production and expand their market reach. Major players are joining forces to leverage their resources and explore new avenues for research and development. For example, Pfizer Inc. and Beam Therapeutics Inc. announced an exclusive four-year research collaboration in January 2022, focused on in vivo base editing programs targeting rare genetic diseases of the liver, muscle, and central nervous system. Similarly, in August 2022, Merck and Orna Therapeutics entered into a collaboration agreement to discover, develop, and commercialize programs, including vaccines and therapeutics, in the areas of infectious disease and oncology, utilizing Orna Therapeutics' engineered circular RNA (oRNA) therapies.

Major companies operating in the nucleic acid based gene therapy market include Celsion Corporation, Wave Life Sciences, Imugene Ltd., Caperna LLC, Phylogica Limited, Protagonist Therapeutics Inc., Benitec Biopharma Ltd., EGEN, BioMedica, Transgene SA, Copernicus Therapeutics Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Alnylam Pharmaceuticals Inc., Amgen Inc., Beam Therapeutics Inc., BioNTech SE, Bluebird Bio Inc., CRISPR Therapeutics AG, Editas Medicine Inc., Genevant Sciences Inc., Homology Medicines Inc., Intellia Therapeutics Inc., Ionis Pharmaceuticals Inc., MaxCyte Inc., Moderna Inc., Novartis International AG, Orchard Therapeutics PLC, Precision BioSciences Inc., REGENXBIO Inc.

North America was the largest region in the nucleic acid-based gene therapy market in 2023. Western Europe was the second-largest region in the nucleic acid-based gene therapy market report. The regions covered in the nucleic acid based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the nucleic acid based gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The nucleic acid based gene therapy market consists of sales of nucleic acid based gene therapy technologies such as anti-sense and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r8976

Table of Contents

1. Executive Summary

2. Nucleic Acid Based Gene Therapy Market Characteristics

3. Nucleic Acid Based Gene Therapy Market Trends And Strategies

4. Nucleic Acid Based Gene Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Nucleic Acid Based Gene Therapy Market Size and Growth

  • 5.1. Global Nucleic Acid Based Gene Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Nucleic Acid Based Gene Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Nucleic Acid Based Gene Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nucleic Acid Based Gene Therapy Market Segmentation

  • 6.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Anti-Sence and Anti-Gene
  • Short Inhibitory Sequences
  • Gene Transfer Therapy
  • Nucleoside Analogs
  • Ribozymes
  • Aptamers
  • Other Technologies
  • 6.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Muscular Dystrophy/ Muscular Disorders
  • Rare Diseases
  • 6.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Academic And Research Institutes

7. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

  • 7.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nucleic Acid Based Gene Therapy Market

  • 8.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nucleic Acid Based Gene Therapy Market

  • 9.1. China Nucleic Acid Based Gene Therapy Market Overview
  • 9.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nucleic Acid Based Gene Therapy Market

  • 10.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nucleic Acid Based Gene Therapy Market

  • 11.1. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nucleic Acid Based Gene Therapy Market

  • 12.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nucleic Acid Based Gene Therapy Market

  • 13.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nucleic Acid Based Gene Therapy Market

  • 14.1. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nucleic Acid Based Gene Therapy Market

  • 15.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview
  • 15.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nucleic Acid Based Gene Therapy Market

  • 16.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nucleic Acid Based Gene Therapy Market

  • 17.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nucleic Acid Based Gene Therapy Market

  • 18.5. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nucleic Acid Based Gene Therapy Market

  • 19.9. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nucleic Acid Based Gene Therapy Market

  • 20.13. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nucleic Acid Based Gene Therapy Market

  • 21.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview
  • 21.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nucleic Acid Based Gene Therapy Market

  • 22.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nucleic Acid Based Gene Therapy Market

  • 23.1. North America Nucleic Acid Based Gene Therapy Market Overview
  • 23.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nucleic Acid Based Gene Therapy Market

  • 24.1. USA Nucleic Acid Based Gene Therapy Market Overview
  • 24.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nucleic Acid Based Gene Therapy Market

  • 25.1. Canada Nucleic Acid Based Gene Therapy Market Overview
  • 25.2. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nucleic Acid Based Gene Therapy Market

  • 26.1. South America Nucleic Acid Based Gene Therapy Market Overview
  • 26.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nucleic Acid Based Gene Therapy Market

  • 27.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nucleic Acid Based Gene Therapy Market

  • 28.1. Middle East Nucleic Acid Based Gene Therapy Market Overview
  • 28.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nucleic Acid Based Gene Therapy Market

  • 29.1. Africa Nucleic Acid Based Gene Therapy Market Overview
  • 29.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By End Uses, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape
  • 30.2. Nucleic Acid Based Gene Therapy Market Company Profiles
    • 30.2.1. Celsion Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Wave Life Sciences
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Imugene Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Caperna LLC
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Phylogica Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Nucleic Acid Based Gene Therapy Market Competitive Benchmarking

32. Global Nucleic Acid Based Gene Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

34. Nucleic Acid Based Gene Therapy Market Future Outlook and Potential Analysis

  • 34.1 Nucleic Acid Based Gene Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Nucleic Acid Based Gene Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Nucleic Acid Based Gene Therapy Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!